Cyrus R. Mehta

12.9k total citations · 4 hit papers
137 papers, 8.5k citations indexed

About

Cyrus R. Mehta is a scholar working on Statistics and Probability, Management Science and Operations Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Cyrus R. Mehta has authored 137 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Statistics and Probability, 28 papers in Management Science and Operations Research and 25 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Cyrus R. Mehta's work include Statistical Methods in Clinical Trials (61 papers), Statistical Methods and Bayesian Inference (29 papers) and Diabetes Treatment and Management (24 papers). Cyrus R. Mehta is often cited by papers focused on Statistical Methods in Clinical Trials (61 papers), Statistical Methods and Bayesian Inference (29 papers) and Diabetes Treatment and Management (24 papers). Cyrus R. Mehta collaborates with scholars based in United States, France and United Kingdom. Cyrus R. Mehta's co-authors include Nitin R. Patel, Faı̈ez Zannad, William B. White, George L. Bakris, Christopher P. Cannon, William C. Cushman, Anastasios A. Tsiatis, Craig Wilson, P. Fleck and Stuart Kupfer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Cyrus R. Mehta

134 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

2013 1.9k citations William B. White, Christopher P. Cannon et al. New England Journal of Medicine profile →
A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables

1983 785 citations Cyrus R. Mehta, Nitin R. Patel Journal of the American Statistical Association profile →
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

2015 551 citations Faı̈ez Zannad, Christopher P. Cannon et al. profile →
Adaptive Designs for Clinical Trials

2016 295 citations Cyrus R. Mehta et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cyrus R. Mehta United States	38	2.7k	2.1k	1.5k	1.3k	1.0k	137	8.5k
Scott S. Emerson United States	50	2.2k 0.8×	1.1k 0.5×	1.5k 1.0×	1.7k 1.4×	680 0.7×	154	11.3k
R. John Simes Australia	37	2.6k 1.0×	868 0.4×	1.2k 0.8×	3.4k 2.7×	845 0.8×	97	9.8k
Philip Hougaard Denmark	45	2.8k 1.1×	2.1k 1.0×	782 0.5×	1.7k 1.4×	245 0.2×	104	8.5k
Dean Follmann United States	42	1.7k 0.6×	1.3k 0.7×	1.1k 0.7×	960 0.8×	393 0.4×	170	10.5k
Laurence S. Freedman Israel	66	675 0.3×	2.3k 1.1×	1.6k 1.1×	1.5k 1.2×	2.4k 2.4×	272	18.0k
Michael A. Proschan United States	49	1.1k 0.4×	1.4k 0.7×	798 0.5×	956 0.8×	409 0.4×	153	15.2k
Thomas Scheike Denmark	48	1.1k 0.4×	1.3k 0.6×	1.3k 0.9×	854 0.7×	477 0.5×	199	9.2k
Charles Kooperberg United States	57	1.3k 0.5×	1.1k 0.5×	4.8k 3.3×	710 0.6×	1.1k 1.1×	197	12.9k
Patrick J. Heagerty United States	59	829 0.3×	2.2k 1.1×	1.9k 1.3×	2.7k 2.1×	1.7k 1.7×	278	18.3k
Paul C. Lambert United Kingdom	53	1.0k 0.4×	2.1k 1.0×	743 0.5×	1.4k 1.1×	2.6k 2.6×	225	12.8k

Countries citing papers authored by Cyrus R. Mehta

Since Specialization

Citations

This map shows the geographic impact of Cyrus R. Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrus R. Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrus R. Mehta more than expected).

Fields of papers citing papers by Cyrus R. Mehta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyrus R. Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrus R. Mehta. The network helps show where Cyrus R. Mehta may publish in the future.

Co-authorship network of co-authors of Cyrus R. Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Cyrus R. Mehta. A scholar is included among the top collaborators of Cyrus R. Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyrus R. Mehta. Cyrus R. Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tamhane, Ajit C., et al.. (2025). Testing One Primary and Two Secondary Endpoints in a Two‐Stage Group Sequential Trial With Extensions. Statistics in Medicine. 44(3-4). e10346–e10346. 1 indexed citations

Park, Jay, Behnam Sharif, Ofir Harari, et al.. (2022). Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials. JAMA Network Open. 5(7). e2221140–e2221140. 25 indexed citations

Liu, Lingyun, et al.. (2021). A simulation‐based comparison of estimation methods for adaptive and classical group sequential clinical trials. Pharmaceutical Statistics. 21(3). 599–611. 3 indexed citations

Ferreira, João Pedro, Patrick Rossignol, George L. Bakris, et al.. (2021). Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial. American Journal of Nephrology. 52(12). 969–976. 3 indexed citations

Ferreira, João Pedro, Cyrus R. Mehta, Abhinav Sharma, et al.. (2020). Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial. BMC Medicine. 18(1). 165–165. 17 indexed citations

Mehta, Cyrus R., et al.. (2018). An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial). Annals of Oncology. 30(1). 103–108. 48 indexed citations

Hwang, You‐Cheol, David A. Morrow, Christopher P. Cannon, et al.. (2017). High‐sensitivity C ‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE ( Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care ) trial. Diabetes Obesity and Metabolism. 20(3). 654–659. 30 indexed citations

Liu, Lingyun, et al.. (2017). Design and Monitoring of Multi-Arm Multi-Stage Clinical Trials. Biometrics. 73(4). 1289–1299. 30 indexed citations

White, William B., Stuart Kupfer, Steven Nissen, et al.. (2014). CARDIOVASCULAR MORTALITY IN PATIENTS WITH TYPE 2 DIABETES AND RECENT ACUTE CORONARY SYNDROMES FROM THE EXAMINE TRIAL. Journal of the American College of Cardiology. 63(12). A116–A116. 6 indexed citations

10.

White, William B., Christopher P. Cannon, Simon Heller, et al.. (2013). Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes. New England Journal of Medicine. 369(14). 1327–1335. 1857 indexed citations breakdown →

11.

Ravandi, Farhad, Ellen K. Ritchie, Hamid Sayar, et al.. (2012). VALOR, an adaptive design, pivotal phase III trial of vosaroxin or placebo in combination with cytarabine in first relapsed or refractory acute myeloid leukemia.. Journal of Clinical Oncology. 30(15_suppl). TPS6637–TPS6637. 5 indexed citations

12.

Mehta, Cyrus R. & Stuart Pocock. (2010). Adaptive increase in sample size when interim results are promising: A practical guide with examples. Statistics in Medicine. 30(28). 3267–3284. 194 indexed citations

13.

Santner, Thomas J., Vivek Pradhan, Pralay Senchaudhuri, Cyrus R. Mehta, & Ajit C. Tamhane. (2006). Small-sample comparisons of confidence intervals for the difference of two independent binomial proportions. Computational Statistics & Data Analysis. 51(12). 5791–5799. 22 indexed citations

14.

Corcoran, Christopher & Cyrus R. Mehta. (2002). Exact level and power of permutation, bootstrap, and asymptotic tests of trend. Journal of Modern Applied Statistical Methods. 1(1). 32–41. 16 indexed citations

15.

Agresti, Alan, Joseph B. Lang, & Cyrus R. Mehta. (1993). Some empirical comparisons of exact, modified exact, and higher-order asymptotic tests of independence for ordered categorical variables. Communications in Statistics - Simulation and Computation. 22(1). 1–18. 3 indexed citations

16.

Mehta, Cyrus R., Nitin Patel, & Pralay Senchaudhuri. (1992). Exact Stratified Linear Rank Tests for Ordered Categorical and Binary Data. Journal of Computational and Graphical Statistics. 1(1). 21–40. 37 indexed citations

17.

Aisner, Seena C., et al.. (1989). The clinical significance of variant morphology small cell carcinoma of the lung. Lung Cancer. 5(1). 20–20. 1 indexed citations

18.

Gupta, Priti, Mira Aghi, R. B. Bhonsle, et al.. (1986). An intervention study of tobacco chewing and smoking habits for primary prevention of oral cancer among 12,212 Indian villagers.. PubMed. 307–18. 19 indexed citations

19.

Mehta, Cyrus R. & Nitin R. Patel. (1983). A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables. Journal of the American Statistical Association. 78(382). 427–434. 785 indexed citations breakdown →

20.

Vincent, R. G., Cyrus R. Mehta, Robert D. Tucker, et al.. (1980). Chemotherapy of extensive large cell and adenocarcinoma of the lung. A randomized trial in 210 patients. Cancer. 46(2). 256–260. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact